[Long-term outcome of radiation therapy for exudative age-related macular degeneration in Japan].
To evaluate the long-term outcome of radiation therapy in eyes with exudative age-related macular degeneration (AMD). Eighty eyes of 80 patients (54 men and 26 women) with exudative AMD, which underwent radiation therapy with a photon beam of 20 Gy (2 Gy per day for 10 days) between 1998 and 2003, were retrospectively reviewed. Average age was 69 +/- 8.1 and follow-up period was 66 months. Best-corrected visual acuity (BCVA), additional therapies and complications were assessed. Mean duration till the best value of postoperative BCVA could be reached was 10 months. The best BCVA was improved in 20 eyes (25.0%), stabilized in 56 eyes (70.0%), and deteriorated in 4 eyes (5.0%). On the final visit visual improvement was observed in 9 (11.3%), stabilization in 25 (31.3%), and deterioration in 46 eyes (57.5%). Additional therapies for exudative AMD were performed in 24 eyes (30.0%). Severe subretinal hemorrhage was observed in 9 eyes (11.3%), which resulted in severe vision loss despite additional vitrectomy. Low-dose radiation therapy for exudative AMD achieved short-term efficacy but seemed less effective in the long-term.